{
  "@type": "dcat:Dataset",
  "accessLevel": "public",
  "bureauCode": [
    "009:25"
  ],
  "contactPoint": {
    "@type": "vcard:Contact",
    "fn": "NIH/NCBI Data Team",
    "hasEmail": "mailto:info@ncbi.nlm.nih.gov"
  },
  "description": "The infusion preparation for peripheral parenteral administration comprises an infusion (A) containing glucose with 80 to 200 g/L concentration, and an infusion (B) containing amino acid with 50 to 150 g/L concentration. The infusion (A) and the infusion (B) are separately put into a vessel that is divided with an openable partition means. The infusion (A) does not contain sulfite, has titratable acidity of 1 or less, contains vitamin B1 and is adjusted to pH 3 to 5. The infusion (B) is adjusted to pH 6.5 to 8. After mixing the both infusions, the mixture has pH 6 to 7.5 and titratable acidity of 5 to 10.",
  "distribution": [
    {
      "@type": "dcat:Distribution",
      "description": "Access the complete Patent AT-E399556-T1: [Translated] TRANSFUSION PREPARATION FOR PERIPHERAL INTRAVENOUS ADMINISTRATION AND METHOD FOR STABILIZING VITAMIN B1 on the official website.",
      "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E399556-T1",
      "mediaType": "text/html",
      "title": "Official Data Source"
    }
  ],
  "identifier": "https://healthdata.gov/api/views/tazs-nku2",
  "issued": "2025-09-05",
  "keyword": [
    "chemistry",
    "innovation",
    "patent",
    "pubchem",
    "research"
  ],
  "landingPage": "https://healthdata.gov/d/tazs-nku2",
  "modified": "2025-09-06",
  "programCode": [
    "009:066"
  ],
  "publisher": {
    "@type": "org:Organization",
    "name": "National Center for Biotechnology Information (NCBI)"
  },
  "theme": [
    "NIH"
  ],
  "title": "Patent AT-E399556-T1: [Translated] TRANSFUSION PREPARATION FOR PERIPHERAL INTRAVENOUS ADMINISTRATION AND METHOD FOR STABILIZING VITAMIN B1"
}